Pharmaceuticals

Lucky Core Industries expands portfolio with Pfizer assets acquisition

Citi Pharma, Hangzhou Newsea partner to boost local API manufacturing

Saudi investors exit Pakistan's largest pharmacy chain. What happened and why?

The magic pill for the pharma sector

AGP acquires portfolio of products from American pharma firm Viatris

PPMA vs DRAP: Pharma crisis continues 

Pricing dispute causes shortage of critical medicine

Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen

The mechanics behind the panadol shortage

Where did all the Burnol go?

Pharmaceuticals: how the locals are beating the multinationals

UK report claims Pakistan's Covid-19 medicine enough for national demand

Pharma industry protests govt's refusal to increase drug prices

Pharmaceuticals in Pakistan: extracting whatever they can from the pie

Govt takes away drug pricing power from pharmaceutical companies 

Britain nears 500 million pound deal for Sanofi, GSK Covid-19 vaccine

Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh

Pharmaceuticals may turn to Chinese raw material as tensions with India soar

Previous1...34567Next